These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28196483)

  • 1. Aortic stiffening precedes onset of heart failure with preserved ejection fraction in patients with asymptomatic diastolic dysfunction.
    Karagodin I; Aba-Omer O; Sparapani R; Strande JL
    BMC Cardiovasc Disord; 2017 Feb; 17(1):62. PubMed ID: 28196483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
    Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
    Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition from asymptomatic diastolic dysfunction to heart failure with preserved ejection fraction: roles of systolic function and ventricular distensibility.
    Aizawa Y; Sakata Y; Mano T; Takeda Y; Ohtani T; Tamaki S; Omori Y; Tsukamoto Y; Hirayama A; Komuro I; Yamamoto K
    Circ J; 2011; 75(3):596-602. PubMed ID: 21282875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction: J-TASTE Trial.
    Takahama H; Asakura M; Abe Y; Ajioka M; Aonuma K; Anzai T; Hayashi T; Hiramitsu S; Kawai H; Kioka H; Kimura K; Lim YJ; Matsuoka K; Motoki H; Nagata Y; Nakamura S; Ohte N; Ozaki Y; Sasaoka T; Tamaki S; Hamasaki T; Kitakaze M;
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):381-388. PubMed ID: 29974299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Phenogroups in patients with subclinical diastolic dysfunction using unsupervised statistical learning.
    Kaptein YE; Karagodin I; Zuo H; Lu Y; Zhang J; Kaptein JS; Strande JL
    BMC Cardiovasc Disord; 2020 Aug; 20(1):367. PubMed ID: 32795252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.
    Reddy YNV; Andersen MJ; Obokata M; Koepp KE; Kane GC; Melenovsky V; Olson TP; Borlaug BA
    J Am Coll Cardiol; 2017 Jul; 70(2):136-148. PubMed ID: 28683960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction.
    Edwards NC; Ferro CJ; Townend JN; Steeds RP
    Heart; 2008 Aug; 94(8):1038-43. PubMed ID: 18308865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction.
    Michalski B; Trzciński P; Kupczyńska K; Miśkowiec D; Pęczek Ł; Nawrot B; Lipiec P; Kasprzak JD
    Cardiol J; 2017; 24(1):35-42. PubMed ID: 27748500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial Stiffness Is Significantly Associated With Left Ventricular Diastolic Dysfunction in Patients With Cardiovascular Disease.
    Namba T; Masaki N; Matsuo Y; Sato A; Kimura T; Horii S; Yasuda R; Yada H; Kawamura A; Takase B; Adachi T
    Int Heart J; 2016 Dec; 57(6):729-735. PubMed ID: 27829641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Sympathetic Denervation in Patients With Heart Failure With Preserved Ejection Fraction.
    Kresoja KP; Rommel KP; Fengler K; von Roeder M; Besler C; Lücke C; Gutberlet M; Desch S; Thiele H; Böhm M; Lurz P
    Circ Heart Fail; 2021 Mar; 14(3):e007421. PubMed ID: 33706547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal, circumferential and radial systolic left ventricular function in patients with heart failure and preserved ejection fraction.
    Gregorova Z; Meluzin J; Stepanova R; Sitar J; Podrouzkova H; Spinarova L
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):385-92. PubMed ID: 26948032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular-vascular dynamics in pediatric patients with heart failure and preserved ejection fraction.
    Masutani S; Kuwata S; Kurishima C; Iwamoto Y; Saiki H; Sugimoto M; Ishido H; Senzaki H
    Int J Cardiol; 2016 Dec; 225():306-312. PubMed ID: 27744267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in left ventricular afterload and diastolic function are independent from the aortic size.
    Sorimachi H; Kurosawa K; Yoshida K; Obokata M; Noguchi T; Naka M; Tange S; Kurabayashi M; Negishi K
    PLoS One; 2019; 14(4):e0214907. PubMed ID: 30947284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis.
    Penicka M; Bartunek J; Trakalova H; Hrabakova H; Maruskova M; Karasek J; Kocka V
    J Am Coll Cardiol; 2010 Apr; 55(16):1701-10. PubMed ID: 20394874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction.
    Reil JC; Hohl M; Reil GH; Granzier HL; Kratz MT; Kazakov A; Fries P; Müller A; Lenski M; Custodis F; Gräber S; Fröhlig G; Steendijk P; Neuberger HR; Böhm M
    Eur Heart J; 2013 Sep; 34(36):2839-49. PubMed ID: 22833515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial contractile dysfunction associated with increased 3-month and 1-year mortality in hospitalized patients with heart failure and preserved ejection fraction.
    Zhong L; Ng KK; Sim LL; Allen JC; Lau YH; Sim DK; Lee RK; Poh KK; Chua TS; Kassab GS; Kwok BW; Tan RS
    Int J Cardiol; 2013 Oct; 168(3):1975-83. PubMed ID: 23336957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.
    Obokata M; Nagata Y; Kado Y; Kurabayashi M; Otsuji Y; Takeuchi M
    J Card Fail; 2017 Mar; 23(3):216-220. PubMed ID: 27737768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.
    Borlaug BA; Lam CS; Roger VL; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2009 Jul; 54(5):410-8. PubMed ID: 19628115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased proximal arterial stiffness and cardiac response with moderate exercise in patients with heart failure and preserved ejection fraction.
    Tartière-Kesri L; Tartière JM; Logeart D; Beauvais F; Cohen Solal A
    J Am Coll Cardiol; 2012 Jan; 59(5):455-61. PubMed ID: 22281248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.